236 related articles for article (PubMed ID: 12974791)
1. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review.
Ramasubbu K; Mullick T; Koo A; Hussein M; Henderson JM; Mullen KD; Avery RK
Transpl Infect Dis; 2003 Jun; 5(2):98-103. PubMed ID: 12974791
[TBL] [Abstract][Full Text] [Related]
2. Postural epigastric pain as a sign of cytomegalovirus gastritis in renal transplant recipients: a case-based review.
Li W; Fan H; Yiping L
Transplant Proc; 2009 Nov; 41(9):3956-8. PubMed ID: 19917423
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
Boctor FN
Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathy after living-donor liver re-transplantation.
Matsusaki T; Morimatsu H; Sato T; Sato K; Mizobuchi S; Morita K
J Anesth; 2010 Aug; 24(4):614-7. PubMed ID: 20458598
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy.
Jeejeebhoy FM; Zaltzman JS
Transplantation; 1998 Jun; 65(12):1645-8. PubMed ID: 9665084
[TBL] [Abstract][Full Text] [Related]
6. Late mortality from thrombotic microangiopathy after liver transplantation: report of a case.
Akamatsu N; Sugawara Y; Tamura S; Togashi J; Kaneko J; Makuuchi M
Surg Today; 2007; 37(4):345-8. PubMed ID: 17387572
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.
Java A; Edwards A; Rossi A; Pandey R; Gaut J; Delos Santos R; Miller B; Klein C; Brennan D
Transpl Int; 2015 Sep; 28(9):1121-5. PubMed ID: 25864519
[TBL] [Abstract][Full Text] [Related]
8. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
Noble S; Faulds D
Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
[TBL] [Abstract][Full Text] [Related]
9. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.
Avsar Y; Cicinnati VR; Kabar I; Wolters H; Anthoni C; Schmidt HH; Beckebaum S
J Clin Virol; 2014 Jun; 60(2):177-80. PubMed ID: 24703746
[TBL] [Abstract][Full Text] [Related]
10. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kisilisik AT; Trofe J; Alloway RR; Gaber LW; Gaber AO
Transpl Infect Dis; 2001 Mar; 3(1):8-15. PubMed ID: 11429034
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
[TBL] [Abstract][Full Text] [Related]
12. [Thrombotic microangiopathy after kidney transplantation].
Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
[TBL] [Abstract][Full Text] [Related]
13. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients.
Mengelle C; Rostaing L; Weclawiak H; Rossignol C; Kamar N; Izopet J
J Med Virol; 2015 May; 87(5):836-44. PubMed ID: 25655981
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.
Turgeon N; Fishman JA; Doran M; Basgoz N; Tolkoff-Rubin NE; Cosimi AB; Rubin RH
Transpl Infect Dis; 2000 Mar; 2(1):2-10. PubMed ID: 11429003
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper.
Trotter JF; Wallack A; Steinberg T
Transpl Infect Dis; 2003 Dec; 5(4):174-80. PubMed ID: 14987201
[TBL] [Abstract][Full Text] [Related]
18. Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy.
Reddy V; Hao Y; Lipton J; Meharchand J; Minden M; Mazzulli T; Chan C; Messner HA
J Clin Virol; 1999 Aug; 13(3):149-59. PubMed ID: 10443791
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
[TBL] [Abstract][Full Text] [Related]
20. [Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney].
Slavicek J; Puretić Z; Glavas-Boras S; Smalcelj R; Barisić I; Vuković J; Seso-Simić D; Slavicek V; Humar I; Kes P
Acta Med Croatica; 2003; 57(1):87-90. PubMed ID: 12876872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
